Selectis Health (GBCS) Gains from Investment Securities (2017)

Selectis Health (GBCS) posted Gains from Investment Securities of $42191.0 for Q4 2017, up 113.25% sequentially from $19785.0 in Q3 2017.

Selectis Health (GBCS) Gains from Investment Securities (2017) Analysis & Trends

Selectis Health has reported Gains from Investment Securities for 1 years, with the latest figure at $42191.0 in Q4 2017.

Quarterly Gains from Investment Securities changed N/A year-over-year to $42191.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $121435.0 (changed N/A YoY) and the FY2017 annual result came in at $121435.0, up 18.73% from the prior year.
Gains from Investment Securities grew to $42191.0 in Q4 2017 per GBCS's latest filing, from $19785.0 in the prior quarter.
Over five years, Gains from Investment Securities peaked at $42565.0 in Q2 2017 and troughed at $16894.0 in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn
10	Selectis Health	17.18 Mn	16.16 Mn	2.67 Mn

Download Data